The State of Metabolic Health in America, 2026 Baseline Edition · James M. Knox · DOI: 10.5281/zenodo.22772957 · Last reviewed: October 2026

Economic Impact

Series EI · The State of Metabolic Health in America, 2026 Baseline Edition

Overview

The direct and indirect economic burden of metabolic disease in the United States, including national health expenditures, diabetes cost estimates, employer productivity losses, and mortality disparities by geography and race.

This series contains 10 metrics in the 2026 Baseline Edition. Each metric cites a primary source. Where sources disagree, both figures and the reason for the discrepancy are documented rather than reconciled.

Metrics in This Series

Series EI metrics — The State of Metabolic Health in America, 2026 Baseline Edition
Metric IDMetricValueData YearPrimary Source
EI-01U.S. national health expenditures$5.3 trillion2024CMS, National Health Expenditure Accounts
EI-02Total economic cost of diagnosed diabetes$412.9 billion2022American Diabetes Association
EI-03Direct medical costs of diagnosed diabetes$306.6 billion2022American Diabetes Association
EI-04Indirect costs of diagnosed diabetes (lost productivity)$106.3 billion2022American Diabetes Association
EI-05Annual illness-related lost productivity for U.S. employers$575 billion2024Integrated Benefits Institute
EI-06Diabetes- and hypertension-related mortality, rural adults85.62020CDC
EI-07Diabetes- and hypertension-related mortality, urban adults71.72020CDC
EI-08Adult obesity prevalence, Black adults49.9%2024CDC, BRFSS
EI-09Adult obesity prevalence, Hispanic adults45.6%2024CDC, BRFSS
EI-10Adult obesity prevalence, white adults41.4%2024CDC, BRFSS

Methodological Notes

Metrics in this series draw on federal surveys, administrative data, and peer-reviewed literature. Where two sources report different figures for the same condition, both are documented with the reason for the discrepancy — typically differences in survey population, measurement method, or case definition.

See Methodology for the full source selection criteria, metric ID system, and conflict resolution approach.

Data Gaps in This Series

Specific data gaps for this series are documented on the Data Gaps page. The report names what is not measured rather than estimating missing values.

How to cite this page

Knox, J. M. (2026). Economic Impact (Series EI). In The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report. Zenodo. https://doi.org/10.5281/zenodo.22772957

© 2026 James M. Knox. Figures may be reproduced with attribution: Knox, J. M. (2026). The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report. Zenodo. https://doi.org/10.5281/zenodo.22772957 ISSN 3144-8178 (Online)